21.5 C
New York
Saturday, June 3, 2023

There’s No Need To Panic Or Freeze When It Comes To Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Ironwood Pharmaceuticals Inc. (IRWD) shows that investor sentiment remained same, with the stock’s consolidated last price remained same by $0.00, or 0.00%, to $10.73. The Ironwood Pharmaceuticals Inc. has recorded 21,469 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $10.73 and fluctuated between $10.84 as its day high and $10.57 as its day low. The current market capitalization of Ironwood Pharmaceuticals Inc. is $1.63B. A total of 2.13 million shares were traded on the day, compared to an average of 2.47M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, IRWD has seen 9 BUY and 20 SELL insider trades, representing the acquisition of 606,841 and the disposition of 210,861 shares. Over the last 12 months, there were 26 BUYs and 38 SELLs from insiders. Insiders purchased 1,165,530 shares during that period but sold 773,759.

In the most recent transaction, MCCOURT Thomas A sold 36,000 shares of IRWD for 10.12 per share on May 22. After the transaction, the Chief Executive Officer now owns 784,916 company shares. In a previous transaction on May 22, Shetzline Michael sold 10,324 shares at 10.12 per share. IRWD shares that CMO,SVP,Head-Res&Drug owns now total 321,131.

Among the insiders who sold shares, Davis Andrew disposed of 6,305 shares on May 22 at a per-share price of $10.12. This resulted in the SVP, Chief Business Officer holding 219,327 shares of IRWD after the transaction. In another insider transaction, MCCOURT Thomas A sold 21,148 shares at $10.62 per share on May 08. Company shares held by the Chief Executive Officer now total 820,916.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for IRWD in the last 3 months, the mean price target is $14.33 with high estimates of $19.00 and low estimates of $9.00. In terms of 52-week highs and lows, IRWD has a high of $12.66 and a low of $9.73.

As of this writing, IRWD has an earnings estimate of $0.25 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.26 per share and a lower estimate of $0.23.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IRWD’s latest balance sheet shows that the firm has $620.13M in Cash & Short Term Investments as of fiscal 2021. There were $475.80M in debt and $161.70M in liabilities at the time. Its Book Value Per Share was $4.58, while its Total Shareholder’s Equity was $605.91M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRWD is Buy with a score of 4.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles